Literature DB >> 7381068

Behçet's disease and treatment with colchicine.

A Raynor, A D Askari.   

Abstract

A case of Behçet's disease characterized by anterior uveitis, arthritis, oral, genital, and cutaneous lesions, as well as gastrointestinal involvement, all documented over a 10-month period, is presented. Less commonly appreciated complications, such as pyoderma gangrenosum, hidradenitis suppurativa, perianal fistula, and persisting leukocytosis, were among striking clinical features of the patient's history. Remission of cutaneous lesions and no recurrence of ocular or gastrointestinal manifestations occurred with 0.6 mg oral colchicine twice daily in a period of 5 weeks.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381068     DOI: 10.1016/s0190-9622(80)80363-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Behçet's disease in patients of west African and Afro-Caribbean origin.

Authors:  W Poon; D H Verity; G L Larkin; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Severe atypical Behçet's syndrome.

Authors:  D R Park; W C Liles; P Kirby
Journal:  West J Med       Date:  1994-01

3.  Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens.

Authors:  Eleni Karatza; George Ismailos; Vangelis Karalis
Journal:  Xenobiotica       Date:  2021-04-12       Impact factor: 1.908

4.  B-nor-methylene Colchicinoid PT-100 Selectively Induces Apoptosis in Multidrug-Resistant Human Cancer Cells via an Intrinsic Pathway in a Caspase-Independent Manner.

Authors:  Andreas Stein; Persefoni Hilken Née Thomopoulou; Corazon Frias; Sina M Hopff; Paloma Varela; Nicola Wilke; Arul Mariappan; Jörg-Martin Neudörfl; Alexey Yu Fedorov; Jay Gopalakrishnan; Benoît Gigant; Aram Prokop; Hans-Günther Schmalz
Journal:  ACS Omega       Date:  2022-01-11

5.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.